RNA — Avidity Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Avidity Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	406	611	595	1,501	1,697
Net Total Accounts Receivable
Net Total Receivables	—	—	1.1	28.2	12.4
Prepaid Expenses
Total Other Current Assets
Total Current Assets	411	623	611	1,542	1,798
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.6	15	16.7	18.3	74.6
Other Long Term Assets
Total Assets	428	639	629	1,564	1,958
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	29.7	51.9	80.7	98	195
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	46.1	60.7	128	139	269
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	381	578	501	1,425	1,689
Total Liabilities & Shareholders' Equity	428	639	629	1,564	1,958
Total Common Shares Outstanding